| Literature DB >> 33968722 |
Lili Shi1,2, Weiya Shi1, Xueqing Peng1, Yi Zhan1, Linxiao Zhou1, Yunpeng Wang1, Mingxiang Feng3, Jinli Zhao4, Fei Shan1, Lei Liu1,5.
Abstract
PURPOSE: To develop and validate a nomogram for differentiating invasive adenocarcinoma (IAC) from adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA) presenting as ground-glass nodules (GGNs) measuring 5-10mm in diameter.Entities:
Keywords: computed tomography; ground-glass nodules; invasive adenocarcinoma; lung cancer; radiomics
Year: 2021 PMID: 33968722 PMCID: PMC8096901 DOI: 10.3389/fonc.2021.618677
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 6.244
Figure 1Flowchart of patient selection procedure.
Characteristics of the patients in the primary cohort and validation cohorts.
| Variable | Primary cohort (n=230) | Internal validation cohort (n=154) | External validation cohort (n=94) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| AIS/MIA (n=166) | IAC (n=64) | p-value | AIS/MIA (n=116) | IAC (n=38) | p-value | AIS/MIA (n=69) | IAC (n=25) | p-value | ||
| 0.175 | 0.823 | 0.600 | ||||||||
| Male | 37 | 20 | 25 | 9 | 18 | 5 | ||||
| Female | 129 | 44 | 91 | 29 | 51 | 20 | ||||
| 0.115 | 0.025 | 0.313 | ||||||||
| ≦40 | 27 | 11 | 28 | 6 | 15 | 2 | ||||
| 40~65 | 124 | 41 | 74 | 20 | 46 | 20 | ||||
| ≥65 | 15 | 12 | 14 | 12 | 8 | 3 | ||||
| <0.001 | <0.001 | 0.002 | ||||||||
| PGGN | 130 | 28 | 86 | 15 | 54 | 11 | ||||
| MGGN | 36 | 36 | 30 | 23 | 15 | 14 | ||||
| 0.479 | 0.002 | 0.917 | ||||||||
| Left upper lobe | 47 | 18 | 32 | 13 | 11 | 4 | ||||
| Left lower lobe | 27 | 11 | 16 | 5 | 11 | 4 | ||||
| Right upper lobe | 46 | 22 | 32 | 18 | 16 | 6 | ||||
| Right middle lobe | 12 | 6 | 9 | 2 | 6 | 3 | ||||
| Right lower lobe | 34 | 7 | 27 | 0 | 9 | 3 | ||||
| 0.233 | 0.692 | 0.130 | ||||||||
| No | 69 | 21 | 37 | 14 | 51 | 14 | ||||
| Yes | 97 | 43 | 79 | 24 | 18 | 11 | ||||
| 0.883 | 0.575 | 0.156 | ||||||||
| No | 88 | 35 | 51 | 19 | 57 | 17 | ||||
| Yes | 78 | 29 | 65 | 19 | 12 | 8 | ||||
| 0.086 | 0.039 | 0.598 | ||||||||
| No | 35 | 21 | 20 | 13 | 17 | 8 | ||||
| Yes | 131 | 43 | 96 | 25 | 52 | 17 | ||||
| 0.062 | 0.056 | 0.047 | ||||||||
| No | 139 | 46 | 99 | 27 | 58 | 16 | ||||
| Yes | 27 | 18 | 17 | 11 | 11 | 9 | ||||
| 0.126 | 0.565 | 0.475 | ||||||||
| No | 112 | 36 | 74 | 22 | 62 | 21 | ||||
| Yes | 54 | 28 | 42 | 16 | 7 | 4 | ||||
| 0.314 | 1.000 | 0.467 | ||||||||
| No | 45 | 13 | 22 | 7 | 27 | 7 | ||||
| Yes | 121 | 51 | 94 | 31 | 42 | 18 | ||||
| 0.044 | 0.080 | 0.261 | ||||||||
| No | 138 | 45 | 93 | 25 | 57 | 18 | ||||
| Yes | 28 | 19 | 23 | 13 | 12 | 7 | ||||
| 7.34 ± 1.38 | 8.08 ± 1.03 | <0.001 | 7.39 ± 1.30 | 8.34 ± 1.17 | <0.001 | 7.86 ± 1.19 | 8.52 ± 1.03 | 0.012 | ||
| -534.73 ± 127.15 | -393.86 ± 168.02 | <0.001 | -522.95 ± 152.19 | -424.04 ± 147.42 | <0.001 | -537.74 ± 112.66 | -409.25 ± 136.30 | <0.001 | ||
| -1.32 ± 0.69 | -0.46 ± 0.75 | <0.001 | -1.17 ± 0.72 | -0.49 ± 0.68 | <0.001 | -0.94 ± 0.63 | -0.24 ± 0.67 | <0.001 | ||
AIS, adenocarcinoma in situ; MIA, minimally invasive adenocarcinoma; IAC, invasive adenocarcinoma; PGGN, pure ground-glass nodule; MGGN, mixed ground-glass nodule; HU, Hounsfield units; Rad-score, radiomics score.
Figure 2Radiomics feature selection using LASSO regression model. (A) Optimal feature selection according to AUC (area under curve) value. The dotted vertical lines were plotted at the optimal λ values based on the minimum criteria and 1 standard error of the minimum criteria. The optimal λ was selected. (B) LASSO coefficient profiles of the 100 radiomics features. Vertical line was drawn at the selected value using 10-fold cross-validation, where optimal λ resulted in five non-zero coefficients.
Independent predictors identified in multivariable logistic regression.
| Feature | OR | 95%CI | p-value |
|---|---|---|---|
| (Intercept) | 0.610 | 0.044~8.234 | 0.710 |
| Bubble-like appearance | 2.333 | 1.036~5.271 | 0.040 |
| Tumor-lung interface (clear vs not clear) | 0.518 | 0.237~1.130 | 0.097 |
| Mean CT value | 1.003 | 1.000~1.007 | 0.071 |
| Average diameter | 1.371 | 1.015~1.871 | 0.042 |
| Rad-score | 3.525 | 1.630~8.255 | 0.002 |
OR, odds ratio; CI, confidence interval; Rad-score, radiomics score.
Figure 3Nomogram of the model combining radiomics signatures and radiological features for predicting the risk of invasive adenocarcinoma. IAC, invasive adenocarcinoma; Rad-score, radiomics score.
Figure 4Receiver operating characteristic (ROC) curves of the radiological features model, radiomics features model and nomogram model in the primary cohort (A), the internal validation cohort (B) and the external validation cohort (C). AUC, Area under curve.
Figure 5Calibration curves of the nomogram model showing the predicted versus actual probability for invasive adenocarcinoma in the primary cohort (A), the internal validation cohort (B) and the external validation cohort (C). IAC, invasive adenocarcinoma.
Figure 6Decision curves of the nomogram model for predicting the risk of invasive adenocarcinoma in the primary cohort (A), the internal validation cohort (B) and the external validation cohort (C). The black line represents the assumption that no patients have IAC. The gray line represents the assumption that all patients have IAC. The red line represents the net benefit of using the nomogram model to predict IAC. The decision curve demonstrates that if the threshold probability is >10%, using the nomogram for IAC prediction adds more benefit than predicting either all or no patients. IAC: invasive adenocarcinoma.